Corona Remedies Ltd (CORONA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039887,
    "name": "Corona Remedies",
    "stock_name": "Corona Remedies",
    "full_name": "Corona Remedies Ltd",
    "name_url": "stocks-analysis/corona-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,829.40",
    "chg": 37.05,
    "chgp": "2.07%",
    "dir": 1,
    "prev_price": "1,792.35",
    "mcapval": "11,282.00 Cr",
    "mcap": "",
    "scripcode": 544644,
    "symbol": "CORONA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE02ZQ01018",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.71 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-downgraded-to-sell-amid-technical-and-financial-concerns-4000415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CoronaRemediesL_mojoScore_4000415.png",
        "date": "2026-05-20 08:33:57",
        "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 May 2026. This shift reflects a combination of deteriorating technical indicators, flat recent financial performance, and valuation concerns despite the company’s strong return on capital employed and institutional investor interest."
      },
      {
        "title": "Has Corona Remedies Ltd declared dividend?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/has-corona-remedies-ltd-declared-dividend-3990202",
        "imagepath": "",
        "date": "2026-05-13 23:30:37",
        "description": "Corona Remedies Ltd has declared a 100% dividend.\n\nDividend Details:\n- Percentage announced: 100%\n- Ex-date: 19 Jun 26\n\nDividend Yield: 0%\n\nTotal Returns by Period:\nIn the last 3 months, the price return was 7.52%, the dividend return was 0%, resulting in a total return of 7.52%.\n\nOver the last 6 months, there was no price return or dividend return, leading to a total return of 0.0%.\n\nFor the 1-year period, there was no price return or dividend return, resulting in a total return of 0.0%.\n\nIn the last 2 years, there was no price return or dividend return, leading to a total return of 0.0%.\n\nFor the 3-year period, there was no price return or dividend return, resulting in a total return of 0.0%.\n\nIn the last 4 years, there was no price return or dividend return, leading to a total return of 0.0%.\n\nOver the last 5 years, there was no price return or dividend return, resulting in a total return of 0.0%.\n\nOvera..."
      },
      {
        "title": "Corona Remedies Ltd Quality Grade Upgrade Reflects Strengthened Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-quality-grade-upgrade-reflects-strengthened-business-fundamentals-3988371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/CoronaRemediesL_qualitydot_3988371.png",
        "date": "2026-05-13 08:00:15",
        "description": "Corona Remedies Ltd has recently seen its quality grade upgraded from \"does not qualify\" to \"good,\" reflecting notable improvements in its core business fundamentals. This upgrade, announced on 12 May 2026, highlights enhanced operational efficiency, robust capital returns, and prudent debt management, positioning the small-cap pharmaceutical company favourably within its sector despite recent share price volatility."
      }
    ],
    "total": 3,
    "sid": "10039887",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/corona-remedies-10039887"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Jun-2026",
      "details": "Newspaper Publication - Notice of 22nd Annual General Meeting Intimation of Record Date and E-voting information",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 22Nd Annual General Meeting",
      "datetime": "15-Jun-2026",
      "details": "Notice of 22nd Annual General Meeting scheduled to be held on Thursday July 09 2026",
      "source": "BSE"
    },
    {
      "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
      "datetime": "15-Jun-2026",
      "details": "Business Responsibility and Sustainability Reporting for the F.Y. 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26",
          "dt": "2026-06-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Corona Remedies Ltd Downgraded to Sell Amid Technical and Financial Concerns

2026-05-20 08:33:57

Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 May 2026. This shift reflects a combination of deteriorating technical indicators, flat recent financial performance, and valuation concerns despite the company’s strong return on capital employed and institutional investor interest.

Has Corona Remedies Ltd declared dividend?

2026-05-13 23:30:37

Corona Remedies Ltd has declared a 100% dividend. Dividend Details: - Percentage announced: 100% - Ex-date: 19 Jun 26 Dividend Yield: 0% Total Returns by Period: In the last 3 months, the price return was 7.52%, the dividend return was 0%, resulting in a total return of 7.52%. Over the last 6 months, there was no price return or dividend return, leading to a total return of 0.0%. For the 1-year period, there was no price return or dividend return, resulting in a total return of 0.0%. In the last 2 years, there was no price return or dividend return, leading to a total return of 0.0%. For the 3-year period, there was no price return or dividend return, resulting in a total return of 0.0%. In the last 4 years, there was no price return or dividend return, leading to a total return of 0.0%. Over the last 5 years, there was no price return or dividend return, resulting in a total return of 0.0%. Overa...

Corona Remedies Ltd Quality Grade Upgrade Reflects Strengthened Business Fundamentals

2026-05-13 08:00:15

Corona Remedies Ltd has recently seen its quality grade upgraded from "does not qualify" to "good," reflecting notable improvements in its core business fundamentals. This upgrade, announced on 12 May 2026, highlights enhanced operational efficiency, robust capital returns, and prudent debt management, positioning the small-cap pharmaceutical company favourably within its sector despite recent share price volatility.

View All News